GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Calmark Sweden AB (FRA:9C7) » Definitions » Notes Receivable

Calmark Sweden AB (FRA:9C7) Notes Receivable : €0.00 Mil (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Calmark Sweden AB Notes Receivable?

Calmark Sweden AB's Notes Receivable for the quarter that ended in Sep. 2023 was €0.00 Mil.


Calmark Sweden AB Notes Receivable Historical Data

The historical data trend for Calmark Sweden AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calmark Sweden AB Notes Receivable Chart

Calmark Sweden AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Notes Receivable
- - - -

Calmark Sweden AB Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Calmark Sweden AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Calmark Sweden AB Notes Receivable Related Terms

Thank you for viewing the detailed overview of Calmark Sweden AB's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Calmark Sweden AB (FRA:9C7) Business Description

Traded in Other Exchanges
Address
Sommargatan 101A, Karlstad Innovation Park, lokal Manegen, Karlstad, SWE, SE-656 37
Calmark Sweden AB provides tests for a newborn. The company's product Calmark's developed a point-of-care (POC) diagnostic instrument which makes it easier and faster to measure biomarkers for disease states in newborns. The company's PNA instrument consists of a reader and a disposable product that is placed in the reader when measured.

Calmark Sweden AB (FRA:9C7) Headlines

No Headlines